DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
3.92
0.19 (5.09%)
At close: Jun 25, 2025, 3:59 PM
3.94
0.51%
After-hours: Jun 25, 2025, 05:02 PM EDT
5.09% (1D)
| Bid | 3.83 |
| Market Cap | 168.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -27M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -6.12 |
| Forward PE | -4.56 |
| Analyst | Buy |
| Ask | 3.95 |
| Volume | 205,267 |
| Avg. Volume (20D) | 109,037 |
| Open | 3.83 |
| Previous Close | 3.73 |
| Day's Range | 3.58 - 3.95 |
| 52-Week Range | 2.49 - 6.82 |
| Beta | 1.20 |
About DMAC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DMAC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DMAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-13.02%
DiaMedica Therapeutics shares are trading lower fo...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
DiaMedica Therapeutics Inc. (DMAC) Q1 2025 Earnings Call TranscriptDiaMedica Therapeutics Inc. (NASDAQ:DMAC ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Rick Pauls - President and Chief Executive Officer Scott Kellen - Chief Financi...
